×
Close
Access complete features of Elixir
Elixir
Drug Screener
Login
×
Close
Searching Query
Please wait while we search for your query
Your search results are ready!
View Results
×
Close
Loading Screen
Please wait while we are loading your screen
Your screen is ready!
View Screen
×
Close
Examiner Insights
USPTO PAIR Documents
File History
PTAB Proceedings
Orange Book
Assignee Citation
Dossier Documents
Events History
Events History
SPC
Unitary Documents
Patent Citation
Litigation Cases
Country-wise Revenue Breakdown
Loading Examiner's Profile.
Loading USPTO PAIR Documents.
Loading PTAB Proceedings.
Loading Orange Book.
Loading Assignee Chart...
Loading Legal Events...
Summary
Full Details
Loading Supplementary Protection Certificates ...
Country
SPC Number
Filed
Granted
Rejected
Extension Date
Event
Event Date
Loading SPC Events...
Loading Unitary Documents...
Loading File History...
Loading File History...
Loading File History...
Loading Litigation Data...
Last updated on -
--
Country
Revenue
Year
Loading...
The data in this table represents approximate values and may not reflect final figures.
EMA Approved Drugs
Filters
Marketing Authorisation Year
to
Market authorisation in the previous
1 year
,
3 years
,
5 years
Data Exclusivity Expiry Year
to
Data exclusivity expiring in the next
1 year
,
3 years
,
5 years
Market Exclusivity Expiry Year
to
Market exclusivity expiring in the next
1 year
,
3 years
,
5 years
Save Screen
Clear Filters
Last updated: May 31st, 2025
Product
Medicine
Therapeutic Area
Common Name
Marketing Authorisation Date
Data Exclusivity Expiration Date
Market Exclusivity Expiration Date
Company Name
Orphan Drug
Get updates in your inbox
Your Work Email:
*
* Please enter a valid email address
Message for us (Optional):